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Stem cells are classically defined by their multipotent, long-term proliferation, and self-renewal capabilities. Here, we
show that increased antioxidant capacity represents an additional functional characteristic of muscle-derived stem cells
(MDSCs). Seeking to understand the superior regenerative capacity of MDSCs compared with myoblasts in cardiac and
skeletal muscle transplantation, our group hypothesized that survival of the oxidative and inflammatory stress inherent
to transplantation may play an important role. Evidence of increased enzymatic and nonenzymatic antioxidant capacity
of MDSCs were observed in terms of higher levels of superoxide dismutase and glutathione, which appears to confer a
differentiation and survival advantage. Further when glutathione levels of the MDSCs are lowered to that of myoblasts,
the transplantation advantage of MDSCs over myoblasts is lost when transplanted into both skeletal and cardiac muscles.
These findings elucidate an important cause for the superior regenerative capacity of MDSCs, and provide functional
evidence for the emerging role of antioxidant capacity as a critical property for MDSC survival post-transplantation.
INTRODUCTION
Myogenic cell transplantation has been proposed as a prom-
ising therapeutic approach in the treatment of skeletal and
cardiac muscle injury. Early studies of myoblast transplan-
tation into dystrophic skeletal muscle yielded limited regen-
eration of dystrophin-expressing muscle fibers (Beauchamp
et al., 1994; Gussoni et al., 1997; Qu-Petersen et al., 2002).
Similarly, given the limited regenerative ability of cardiac
muscle, cell transplantation has been proposed as an alter-
native to heart transplantation (Assmus et al., 2006; Lunde et
al., 2006; Schachinger et al., 2006).
A major obstacle in both cardiac and skeletal myogenic
therapies is the poor rate of engraftment of myogenic cells
after transplantation (Taylor et al., 1998; Oshima et al., 2005).
In skeletal muscle, numerous groups have observed a rapid
inflammatory response that appears to contribute to rapid
cell loss and limit therapeutic success (Beauchamp et al.,
1994; Gussoni et al., 1997; Beauchamp et al., 1999). Multiple
groups have postulated that the small number of injected
cells that survive transplantation in both cardiac and skeletal
muscle may represent a special subpopulation of stem-like
cells (Qu et al., 1998; Beauchamp et al., 1999; Qu-Petersen et
al., 2002).
For these reasons, our group attempted to isolate this
putative subpopulation of cells using a modified preplate
technique. This procedure was initially developed to purify
myoblasts from nonmyogenic cells, including fibroblasts, of
whole tissue preparations based on the differential adhesion
characteristics of the cells to a collagen coated flask (Rando
and Blau, 1994). Our group modified this technique to iso-
late various populations of myogenic cells, including a pop-
ulation of early adhering preplate (EP) cells and a late adhering
preplate (LP) cell population from which a subpopulation of
long-term proliferating (LTP) cells, also known as muscle
derived stem cells (MDSCs), has been isolated (Gharaibeh et
al., 2008). Although it should be noted that both myoblasts
and MDSCs fuse to one another and with host endogenous
myofibers, forming dystrophin() myofibers, MDSCs dem-
onstrate a superior ability to regenerate skeletal muscle fi-
bers (Jankowski et al., 2001; Qu-Petersen et al., 2002). Simi-
larly, MDSCs injected into hearts after myocardial infarction
improve cardiac function to a greater extent than trans-
planted myoblasts (Oshima et al., 2005; Payne et al., 2007).
MDSCs differ from myoblasts not only in their cell marker
expression but also in their behavior, which includes: long-
term proliferation, multipotency, self-renewal ability, and
their high regenerative capacity. It should be noted that
MDSCs are isolated based on their late adhesion character-
istics and not on their cell marker expression. Although their
cell marker profile has been characterized subsequent to
preplate isolation (Jankowski et al., 2001, 2002; Jankowski
and Huard, 2002; Deasy et al., 2005, 2007), their designation
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as stem cells is multifactorial. It is predicated on their mul-
tipotency, their cell marker expression, their self-renewal
abilities, and most importantly by their significantly in-
creased regenerative capacity when compared with myo-
blasts (Qu-Petersen et al., 2002; Oshima et al., 2005). In fact,
the least reliable method for their appropriate designation as
stem cells has been their maintenance of a stable marker
profile. Myoblasts, on the other hand, differ significantly
from MDSCs in that they cannot usually be cultured for long
periods of time due to their rapid differentiation into myo-
tubes, they express the late myogenic cell marker Pax7 (un-
like MDSCs), and they engraft poorly when transplanted
into the skeletal muscle of mdx mice.
CD34 and Sca1 cell marker expression in MDSCs has been
shown to be influenced by cell culture even after clonal
isolation. Although other groups have used cell markers to
isolate a multipotent cell fraction from skeletal muscle, the
CD34 and Sca-1 marker profiles of MDSCs are heteroge-
neous (Jankowski et al., 2001, 2002). When MDSCs are sorted
using fluorescence-activated cell sorting (FACS) by their
CD34 and Sca-1 expression, heterogeneity is reestablished
after in vitro culture. Furthermore, we have found using
FACS-sorted and clonal populations of MDSCs, that expres-
sion of these two cell markers does not exclusively predict
the engraftment size of dystrophin-() myofibers or regen-
eration index (RI  number of dystrophin() myofibers/
number of cells transplanted) in dystrophin deficient, mdx
mice (Jankowski et al., 2001; Qu-Petersen et al., 2002; Deasy et
al., 2005, 2007).
Several groups have isolated stem cell and early progen-
itor populations from skeletal muscle based on differential
adhesion and cell marker expression (Young et al., 2001;
Gharaibeh et al., 2008). More recently, a skeletal muscle
precursor population was isolated via FACS sorting CD45,
Sca1, Mac1, CXCR4, and 1 integrin subpopulations of
satellite cells (Cerletti et al., 2008), and a myogenic endothe-
lial cell population in skeletal muscle was initially reported
based on CD34 and CD45 expression, which was shown
to improve cardiac function after myocardial infarction (Ta-
maki et al., 2002, 2008a). Tamaki et al. (2007, 2008b) have also
clonally isolated so-called skeletal double-negative cells (Sk-
DN), which are CD34/CD45, and have demonstrated
their multipotency in vitro and in vivo. Our group has
reported a similar population of so-called myoendothelial
cells isolated from human skeletal muscle based on their
coexpression of CD56, CD34, and CD144 (Zheng et al., 2007).
Furthermore, pericytes isolated from skeletal muscle also
display a high regeneration index in skeletal muscle similar
to myogenic endothelial cells and MDSCs (Dellavalle et al.,
2007; Crisan et al., 2008), which has led to the hypothesis that
all of these populations may originate from a blood vessel
wall niche in skeletal muscle (Tamaki et al., 2002; Tavian et
al., 2005; Peault et al., 2007).
Defined by their properties to differentiate into multiple
tissue types, their propensity for self-renewal, and their
capacity for long-term proliferation, stem cells promise to
pave the way for potential cell therapies in the future; how-
ever, oxidative, inflammatory, and other cell stress associ-
ated with transplantation can restrict the regenerative ca-
pacity of these cells. Emerging evidence of increased
antioxidant capacity as a characteristic of stem cells suggests
a further justification for the pursuit of stem cell therapies.
Stem cells may possess an ability to avoid the oxidative
damage to which their more differentiated counterparts,
such as myoblasts, are more vulnerable (Dernbach et al.,
2004; He et al., 2004).
The presence of inflammation at the site of transplantation
in both injured and diseased skeletal and cardiac muscle
suggests that inflammatory and oxidative stress may play an
important role in the regenerative potential of a given cell
population (Beauchamp et al., 1994; Huard et al., 1994; Men-
dell et al., 1995; Fan et al., 1996; Gussoni et al., 1997; Urish et
al., 2005). Inflammation, the associated release of proinflam-
matory cytokines, and oxidative stress have been associated
with multiple types of cell transplantation, including myo-
blast transplantation into skeletal and cardiac muscle (Su-
zuki et al., 2004; Urish et al., 2005), transplantation of pan-
creatic islets (Bottino et al., 2004), and bone marrow
transplantation (Blackwell et al., 2000; Evens et al., 2004). The
destructive power of oxygen is a major component of in-
flammation through its ability to strip electrons and form
highly reactive oxygen species (ROS). After cell transplan-
tation, inflammation via the secretion of cytokines, recruit-
ment of inflammatory cells, and vascular exudation can
induce mechanical perturbation of the microvascular barrier
and local ischemia (Gute et al., 1998; Carden and Granger,
2000). Ischemia and the associated reperfusion injury is di-
rectly linked to the production of various ROS (Kaminski et
al., 2002). In addition to the respiratory burst of inflamma-
tory cells such local ischemia can further induce ROS pro-
duction via xanthine oxidase conversion from xanthine de-
hydrogenase.(Chanock et al., 1994; Nishino, 1994; Gute et al.,
1998; Makazan et al., 2007).
Multiple groups have shown that stem cells appear to
have an increased antioxidant capacity (Dernbach et al.,
2004; He et al., 2004), whereas others have demonstrated the
deleterious role of inflammation and oxidative stress in cell
transplantation (Qu et al., 1998; Suzuki et al., 2000). Our
group has shown that MDSCs have lower rates of stress-
induced cell death, and we have speculated that the MDSCs’
increased regenerative capacity may relate to an increased
resistance to oxidative and inflammatory stress (Oshima et
al., 2005; Deasy et al., 2007). In this article, we extend this
work and hypothesize that the MDSCs’ increased antioxi-
dant capacity may be responsible for the increased regener-
ation capacity of these cells when compared with myoblasts.
MATERIALS AND METHODS
Cell Isolation and Culture
MDSCs were isolated from the skeletal muscle of 3-wk-old C57BL/6J mice
(The Jackson Laboratory, Bar Harbor, ME) as previously described using a
modified version of the preplate technique (Qu-Petersen et al., 2002; Ghara-
ibeh et al., 2008). Myoblasts were isolated from 1–3-wk-old C57BL/6J mice
using this same method as previously described (Qu-Petersen et al., 2002;
Gharaibeh et al., 2008). All cells were cultured and expanded in high-serum
proliferation media (DMEM, 10% fetal bovine serum, 10% horse serum, 1%
penicillin/streptomycin, and 0.5% chick embryo extract). Myoblasts were
cultured for 8 passages before each experiment. The MDSCs that were used
for the transplantation experiments were all 20 passages. It is important to
note that recent work has shown that MDSCs can be cultured past the
Hayflick limit of 200 doublings while preserving their regeneration index and
not exhibiting any abnormal neoplastic transformation properties (Lee et al.,
2000; Deasy et al., 2002, 2003, 2005, 2007).
Fusion Index
The rate and extent of myoblast and MDSC fusion into syncytial myotubes
was monitored after a single 24 h exposure to H2O2 or TNF- to simulate an
oxidative or inflammatory stress challenge. Cells were plated at an initial
density of 1250 cells/cm2 and cultured in high-serum proliferation media.
After 48 h, the culture medium was replaced with low-serum medium
(DMEM, 2% fetal bovine serum, and 1% penicillin/streptomycin) to induce
differentiation. At this point H2O2 (10, 25, 50, and 100 M; Sigma, St. Louis,
MO) and TNF- (1.0, 2.5, and 5.0 ng/ml; R&D Systems, Minneapolis, MN)
was added. Media were replaced daily with fresh differentiation media (with-
out H2O2 or TNF-).
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At days 3 and 4, the cells were fixed in cold methanol and evaluated for the
presence of skeletal fast myosin heavy chain-positive myotubes (1:400, MY-32
clone, Sigma) and counterstained with DAPI (1:1000, Sigma). Fluorescence
microscopy was performed on a Leica DMIRB microscope (Deerfield, IL) with
a Retiga 1300 digital camera (QImaging, Burnaby, BC, Canada). All images
were acquired with Northern Eclipse software (version 6.0; Empix Imaging,
Mississauga, ON, Canada).
These images were used to measure the fusion index (Jankowski et al.,
2002), defined as the ratio of the total number of nuclei in myosin-heavy-
chain–expressing cells compared with the total number of nuclei of the entire
cell population. Each dose- and time-dependent experiment was performed in
triplicate using six randomly selected microscope fields for quantification in
each experiment.
Additional experiments to test the effects of sustained inflammatory stress
(TNF-) on myogenic differentiation were conducted in an identical manner
as described above with the following changes. Fresh differentiation medium
with 5.0 ng/ml TNF- was exchanged daily in each cell population. The
fusion index was measured on days 3, 4, and 7.
Cell Death
MDSCs and myoblasts were cultured for 24 h under normal culture condi-
tions and then incubated in H2O2 (100, 250, and 500 M) at 37°C. After 15 h,
the media were collected; cells were washed in PBS, harvested in 0.01%
trypsin-EDTA (Invitrogen Laboratories, Carlsbad, CA), and resuspended in
proliferation media. The number of apoptotic and necrotic cells was measured
by staining the cells with annexin-V and propidium iodide according to
manufacturer’s directions (BD Bioscience, San Jose, CA) and quantifying their
numbers using FACS (FACSAria; FACSDiva Software; BD Bioscience) with
standard calibration and one-color control for compensation of fluoro-
chromes. Total cell death was determined as the sum of necrotic and apoptotic
cell death fractions normalized to exclude cellular debris.
To monitor the rate of cell death over a continuous time period, a modified
live cell microscopy technique was used to measure percentages of annexin-
V–positive cells. Cells were seeded at an initial density of 2000 cells/cm2 on
collagen Type-I 24-well plates and cultured for 24 h. Cells were loaded with
Cell Tracker Red-CMTPX (Molecular Probes, Eugene, OR) according to man-
ufacturer’s directions to aid in segmentation of the entire cell population.
Cells were then placed in proliferation media containing 15 g/ml annexin-V
FITC (BD Bioscience) and 10 g/ml propidium iodide. A microscope imaging
system (Kairos, Harmarville, PA) was used to acquire light and fluorescent
time-lapsed images on a 30-min time interval (Deasy et al., 2002; Bahnson et
al., 2005). At each time point, nine images in each plate were collected, resulting
in over 45,000 images and 1–3  105 total events being recorded. After an initial
baseline measurement was collected, cells were incubated with increasing doses
of H2O2 (10, 25, 50, 100, 250, and 500 M; Sigma) and TNF- (1.0, 2.5, and 5.0
ng/ml; R&D Systems). Images were collected on a 30-min interval over a 24-h
period. The percentages of annexin-positive cells in each population at each time
period were measured using open source software.
Antioxidant Capacity
The antioxidant capacity of each cell population was assessed by measur-
ing the levels of reduced glutathione (GSH), superoxide dismutase (SOD)
activity, and intracellular ROS after H2O2 challenge. Levels of ROS were
measured using 5-(and-6)-carboxy-2,7-dichlorodihydrofluorescein diac-
etate (carboxy-H2DCFDA; Molecular Probes). Briefly, cells were plated at
2500 cells/cm2 and after 48 h were loaded with 5 M carboxy-H2DCFDA for
30 min in proliferation media, washed, and exposed to 500 M H2O2. At
15-min time intervals, cells were harvested and green fluorescence was im-
mediately measured using flow cytometry (Hempel et al., 1999).
Levels of GSH were monitored using monochlorobimane (MCB; Molecular
Probes), a nonfluorescent bimane that reacts with free GSH to form a highly
fluorescent derivative. Cells were loaded with 4 M of MCB for 30 min in
proliferation media, harvested, washed, and the fluorescence was measured
using FACS with single parameter controls.
Total activity of SOD was measured using a colorimetric assay (Chemicon,
Temecula, CA; APT290). Myoblast and MDSC cell samples containing 2 106
cells were homogenized using a lysis buffer (10 mM Tris, pH 7.5, 150mN
NaCl, 0.1 mM EDTA, and 0.5% Triton X-100) and centrifuged at 12,000 g for
10 min to collect cell lysate. SOD activity was measured according to manu-
facturer’s directions.
GSH Depletion
To assess the role of GSH in regenerative capacity, MDSCs were depleted of
cellular GSH using diethyl maleate (DEM, Sigma), which conjugates directly
with GSH and renders it inactive (Plummer et al., 1981). After 48 h in standard
culture conditions, cells were treated with 50 M DEM for 2 h, washed twice
in PBS, and then cultured in fresh proliferation media. In some in vitro
experiments, other concentrations of DEM were used using the same protocol
where noted in the results section.
Cell Transplantation
All animal surgical procedures were approved by The Institutional Animal
Care and Use Committee, Children’s Hospital of Pittsburgh (Protocol 7/03).
MDSCs and myoblasts were injected into Mdx mice as previously described
(Lee et al., 2000; Qu-Petersen et al., 2002). Briefly, 2  105 viable cells sus-
pended 30 l of PBS were injected into the gastrocnemius muscle of 4–6-wk-
old Mdx mice (C57BL/10ScSn DMDmdx/J, The Jackson Laboratory). The
mice used in the experiment were not immunosuppressed, and the injected
muscle was not injured nor irradiated before or after cell transplantation.
These methods were not used because in our experience immune suppression
and muscle injury (via irradiation or cardiotoxin injection) are not required
for large engraftments of the MDSCs (Qu-Petersen et al., 2002; Deasy et al.,
2007; Cerletti et al., 2008). Because the myoblasts and MDSCs were isolated
from inbred mice with identical backgrounds (C57BL/6J) and are injected into
inbred host mdx mice, any immunological response elicited by the injected
cells should be identical unless the cell type injected is exhibiting an immu-
nologically privileged behavior—a behavior that is, indeed, exhibited by stem
cells (Qu-Petersen et al., 2002).
Coronary artery ligation and cell transplantation into infarcted hearts were
performed in 14-wk-old C57BL/6J mice (Jackson Laboratory), and physiolog-
ical function was measured as previously described (Oshima et al., 2005;
Payne et al., 2007). Briefly, myocardial infarctions were induced by ligating the
left anterior descending coronary artery. Cells (3  105) or PBS were injected
into the anterior, center, and lateral aspects of the infracted myocardium.
Echocardiography (Sequoia C256 system; Siemens, Malvern, PA) was per-
formed at 6 wk to assess the systolic function. Two-dimensional images of the
heart were obtained at the midpapillary muscle level. The end-diastolic area
(EDA) and end-systolic area (ESA) were measured from short-axis images of
the left ventricle. The end-diastolic dimension (EDD) and end-systolic dimen-
sion (ESD) were measured from at least six consecutive beats from an M-
mode tracing. Systolic function was assessed by measuring the fractional
shortening (FS) and fractional area change (FAC), a measure of the change in
length and area of the myocardium during systole, respectively, that repre-
sents the degree of muscle contraction. FS is defined as [(EDD  ESD)/EDD],
and the FAC is defined as [(EDA  ESA)/EDA].
Histological Analysis
Skeletal muscle sections were stained for dystrophin (1:50, Dys-2, Novocastra,
Burlingame, CA) using protocols previously described (Deasy et al., 2007).
Infarct scar on cardiac sections were stained using Mason’s Modified IMEB
Trichrome Stain Kit (International Medical Equipment, San Marcos, CA)
according to manufacturer’s instructions. A mouse anti-fast skeletal myosin
heavy-chain (MHC) antibody (1:400, MY-32 clone, Sigma) and a rat anti-
mouse CD31 antibody (1:1000, Becton Dickinson Pharmingen, San Diego, CA)
was used to immunostain cardiac muscle sections for myofibers and capillar-
ies as previously described (Oshima et al., 2005; Payne et al., 2007). Fluores-
cence and bright field microscopy was performed using Nikon Eclipse E800
microscope (Melville, NY) equipped with a Retiga Exi digital camera (QIm-
aging). All images were acquired with Northern Eclipse software (version 6.0;
Empix Imaging).
The scar tissue ratio was measured from digital images collected at low
power (20) of the entire left ventricle cross section after staining with
Mason’s trichrome. Scar tissue ratio was measured as the number of pixels in
the area of fibrosis to the number of pixels in the entire area of the left
ventricle cross section (six sections/animal). Myofiber engraftment size was
measured as the total number of pixels in the skeletal myofiber engraftment
on the cardiac cross section. The largest engraftment was used for each animal
was used for this measurement. We measured the capillary density by count-
ing the number of CD31 capillary structures per high-power field (200)
within the infarct and MHC area (six images/animal).
Image Analysis
Image analysis using computing software was conducted as noted above to
measure rates of apoptosis over a continuous time period and to measure the
fusion index. All programs, except where noted, were written as open source,
freely available code using the Insight Toolkit, an image segmentation and
registration C code library (Yoo et al., 2002). The area of MHC expression,
the scar tissue ratio, and the capillary density in the induced myocardial
infarction animal model were measured using ImageJ (version 1.23j, National
Institute of Health; http://rsb.info.nih.gov/ij/).
Statistical Analysis
Data are expressed as a mean  SE, except where noted. Direct comparisons
between two cell populations were made using an unpaired, two-tailed
Student’s t test. Statistical significance was determined if p  0.05. All statis-
tical tests were completed using R (R Core Development Team, www.
r-project.org). Comparisons of single groups were completed using one-way
ANOVA. Multiple group comparisons were made using two-way ANOVA.
In both cases, significance levels were determined using the Student-New-
man-Keuls pairwise comparison.
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RESULTS
MDSCs Have Less Oxidative and Inflammatory
Stress–induced Cell Death
Given that MDSCs have demonstrated an increased regen-
erative capacity in both skeletal and myocardial muscle
(Qu-Petersen et al., 2002; Oshima et al., 2005), we hypothe-
sized that the inflammatory response observed at the site of
transplantation is a major determinant in the differential
regenerative capacity of MDSCs and myoblasts. Our pri-
mary objective was to determine if a differential resistance to
oxidative (H2O2) or inflammatory (TNF-) stress could be
observed in vitro between the two cell populations, in terms
of survival, differentiation, and antioxidant capacity.
To test this hypothesis in terms of survival, myoblasts and
MDSCs were exposed to H2O2 (100, 250, 500 M) in vitro for
a period of 18 h to determine if MDSCs have a survival
advantage after oxidative stress. The early apoptotic marker,
annexin-V, and the later apoptotic marker, propidium io-
dide exclusion, were used to measure total cell death using
FACS. Myoblasts had significantly higher rates of cell death
compared with MDSCs at each dose tested (p  0.05; Figure
1A), suggesting that MDSCs were more resistant to oxida-
tive stress–induced cell death after 18 h of exposure. A
limiting factor in these experiments was the ability to only
collect a limited series of measurements at one time point.
This differential resistance to stress was confirmed using a
robotic live-cell microscopy system to measure levels of
annexin-positive cells continuously for a period of 24 h
(Deasy et al., 2003). Using this approach, it was possible to
screen a larger number of doses of H2O2 over a continuous
time period. MDSCs exhibited superior survival rates com-
pared with myoblasts over a broad range of H2O2 concen-
trations (p  0.05; 0, 25, 50, 100, 250 M H2O2; Figures 1B).
Figure 1C is an 18 h time point snapshot of the live-cell
microscopy experiment showing agreement with data ob-
tained in Figure 1A. This observed survival advantage of
MDSCs is lost at a H2O2 concentration of 500 M.
A similar MDSC survival advantage was observed
when both cell populations were exposed to increasing
doses of the inflammatory cytokine TNF- (1.0, 2.5, 5.0
ng/ml), using the same robotic live-cell microscopy sys-
tem. A representative summary of these results at 18 h
reveals that myoblasts have significantly higher rates of
cell death than MDSCs at all doses (p  0.05; Figure 1D).
These results mirror the observations from measuring cell
death after exposure to H2O2.
MDSCs Maintain the Ability to Differentiate After
Oxidative Stress
The capacity of a cell population to differentiate is an im-
portant measure of how well the cell may engraft to and/or
Figure 1. MDSCs have lower rates of cell death after exposure to H2O2 and the inflammatory cytokine TNF- than myoblasts. (A) Total
levels of apoptosis and necrosis were measured at 18 h after exposure to H2O2 using flow cytometry with annexin-V and propidium iodide
staining. (B) Levels of cell death were measured over a continuous 36 h period using time-lapse imaging with annexin-V staining after
exposure to 50 M H2O2. Solid lines represent the mean fraction of annexin-V-positive cells, whereas the range-plot represents the 95%
confidence interval (CI) of these measurements. (C and D) Using the approach outlined in B, levels of annexin-V staining over a 24 h period
were monitored after exposure to increasing doses of H2O2 (C) and TNF- (D). ANOVA; *p  0.05; mean values  CI shown.
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induce regeneration of the host muscle. Therefore, a survival
advantage of MDSCs alone may not be sufficient for their
superior regenerative capacity in skeletal and cardiac mus-
cle. We hypothesized that MDSCs would maintain their
ability to differentiate into myotubes after exposure to oxi-
dative and inflammatory stresses better than myoblasts.
Myogenic differentiation of both MDSC and myoblast cell
populations were measured after exposure to both H2O2 and
TNF-. After high-density culture in low serum media to
induce differentiation, cells were exposed to either H2O2 (10,
25, 100 M) or TNF- (1.0, 2.5, 5.0 ng/ml) for 24 h. After this
24 h stress challenge, the low-serum media were exchanged
on a daily basis. (Note: H2O2 and TNF- were not included
in the media after the stress challenge). Differentiation was
quantified at 3 and 4 d after treatment using the fusion
index, which is defined as the ratio of the total number of
nuclei in fast MHC-expressing cells, a late differentiation
myogenic protein, to the total number of nuclei.
Large differences between the ability of MDSCs and myo-
blasts to form myotubes after exposure to oxidative and
inflammatory stresses were observed at day 3. Representa-
tive images of MDSCs and myoblasts exposed to 100 M
H2O2, and untreated controls show that MDSCs maintained
similar rates of myogenic differentiation after H2O2 expo-
sure, whereas myoblasts had a substantial decrease in myo-
genic differentiation (Figure 2A). Although the fusion index
of MDSCs remained constant at increasing doses of H2O2,
myoblasts had a significant and progressive dose-modu-
lated decrease in their fusion index (p  0.05; Figure 2B). A
similar response was measured when both cell populations
were exposed to TNF- (p  0.05; Figure 2C). In both cases,
the dose response behavior was temporary, given that by
day 4, no difference in the rate of differentiation of myoblasts
or MDSCs was observed (Supplemental Figure S1).
These experiments were conducted using only an initial
temporary stress insult. In general, H2O2 added to cell cul-
ture systems is rapidly neutralized by catalase. Further,
medium was changed on a daily basis, limiting the effects of
TNF-, H2O2, and any additionally generated redox or in-
flammatory species. To extend the time period of exposure
to oxidative and inflammatory stresses, cells undergoing
myogenic differentiation were exposed to a daily, repeated
exposure of TNF- (5 ng/ml) for 1 wk. That is, the low-
serum-differentiation media were supplemented with TNF-
Figure 2. Oxidative and inflammatory stress delays differentiation in myoblasts but not in MDSCs. (A) Representative images of the MHC
expression (red) of MDSCs and myoblasts at day 3 after a 24 h exposure to H2O2 (nuclei stained with dapi in blue) are shown. (A) Bar, 50
m. (B) At day 3, MDSCs exposed to H2O2 displayed similar rates of differentiation as untreated MDSC controls. Myoblasts displayed less
differentiation than myoblast controls. Results were similar with exposure to TNF-. (C) At day 3, MDSCs exposed to TNF- displayed
similar rates of differentiation as untreated MDSC controls. Myoblasts displayed less differentiation than myoblast controls. (D) Myoblast
differentiation inhibited on daily exposure to TNF- (5 ng/ml), whereas MDSC differentiation is unaffected. Data are expressed as an FI ratio
of stressed and unstressed cell groups. (B–D) ANOVA; *p  0.05; mean values  SEM.
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each day it was replaced. This is approximately the concen-
tration of TNF- seen in different pathological conditions
(Vreugdenhil et al., 1992; Chen et al., 2004). For clarity, data
are expressed as a ratio of the fusion index of the stressed
cell group to the unstressed cell group, termed fusion index
(FI) ratio. For example, an FI ratio of 0.5 indicates that the
stressed cell population had 50% of the myogenic differen-
tiation compared with the unstressed cell group at the same
time point. Similar to the previous experiments, the rate of
MDSC myogenic differentiation was unaffected by the expo-
sure. The average fusion index ratio was approximately 1 at
all three time points, indicating that the rate of myogenic
differentiation of stressed MDSCs was nearly identical to the
unstressed MDSCs. In contrast, myoblast differentiation re-
mained suppressed. The average FI ratio was 0.39  0.07
(mean SEM), indicating that stressed myoblasts had40%
of the differentiation as that of unstressed myoblasts (Figure
2D).
MDSCs Exhibit Lower Levels of Intracellular ROS
Given that MDSCs had lower rates of cell death and main-
tained their ability to differentiate compared with myoblasts
after exposure to oxidative stress, we hypothesized that
these differences in survival would correlate with the cells’
sustaining differential oxidative damage. We monitored the
levels of intracellular ROS in MDSCs and myoblasts after
exposure to a high dose of H2O2 (500 M) using FACS with
the fluorescent indicator carboxy-H2DCFDA over a 2 h time
period. Our results indicate that myoblasts had a significant
peak in intracellular ROS concentration 30 min after H2O2
exposure that was sevenfold higher than that of MDSCs for
the same time point (p  0.05; Figure 3A).
MDSCs Have Increased Protection from ROS
Decreased levels of intracellular ROS suggest that MDSCs
have increased antioxidant activity to defend against redox
imbalances. A cell has a vast array of enzymes and com-
pounds to defend against these oxidative stresses including
GSH, SOD, peroxiredoxins, glutathione peroxidase (GPx),
catalase, and others. The dominant forms in terms of activity
are GSH and the multiple isoforms of SOD.
As an initial study of the sources of MDSCs’ increased
antioxidant capacity, we sought to investigate the activity of
GSH and SOD. Basal concentrations of GSH were measured
using FACS after staining with monochlorobimane (MCB).
MDSCs had a 2.5-fold increase in mean fluorescence, reveal-
ing that the differences in GSH levels are significant (p 
0.05; Figure 3B). Total SOD activity was measured using a
colorimetric assay. MDSCs had a 0.5-fold higher level of
total basal SOD activity when compared with myoblasts
(p  0.05; Figure 3C). These experiments combined with
MDSCs having lower levels of ROS after exposure with
H2O2 suggest that MDSCs have an increased antioxidant
capacity when compared with myoblasts.
Decreasing the GSH Levels of MDSCs Decreases the
Regeneration Capacity of MDSCs in Skeletal Muscle
To assess the role antioxidant capacity plays after cell trans-
plantation in vivo, we decreased the MDSC GSH levels to
that similar to myoblasts and measured the regenerative
capacity of the cells after injection into the gastrocnemius
muscles of Mdx mice. For this purpose, cells were exposed to
DEM, a specific, nonprotein thiol-depleting agent that selec-
tively inhibits glutathione activity (Plummer et al., 1981).
After exposure to increasing doses of DEM, the basal levels
of GSH were measured by MCB fluorescence using flow
cytometry. DEM concentrations of 10 or 50 M were found
to reduce the level of GSH in MDSCs to levels comparable to
those in myoblasts (Figure 4, A and B). To ensure that the
overall antioxidant capacity of MDSCs had been reduced to
that comparable to myoblasts, oxidative stress experiments
using the live cell microscopy system were repeated using
DEM-treated (50 M) MDSCs and myoblasts both under
Figure 3. MDSCs have lower degrees of oxidative damage and a
higher antioxidant capacity than myoblasts. (A) Measured intracel-
lular ROS levels after exposure to 500 M H2O2 for 2 h. MDSCs had
little increase in ROS, whereas myoblasts had a large increase. (B)
MDSCs have higher levels of GSH as shown by the mean fluores-
cence after MCB staining. (C) MDSCs had a significantly higher total
SOD activity than myoblasts. (B and C) Student’s t test; *p  0.05;
mean values  SEM.
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conditions of H2O2 stress (100 M). Indeed the DEM-treated
MDSCs had similar rates of cell death as the myoblast pop-
ulation across multiple time points (Figure 4, C and D).
Thus, 50 M of DEM was selected to inhibit MDSCs’ resis-
tance to oxidative stress and make the MDSCs comparable
to myoblasts in terms of antioxidant capacity for the remain-
der of the in vivo experiments.
To clarify the role oxidative stress plays in the regenera-
tive capacity of MDSCs, an equal number of myoblasts,
untreated MDSCs, and DEM-treated MDSCs were injected
into the gastrocnemius of Mdx mice. After 2 wk, the regen-
eration index was measured. MDSCs regenerated a signifi-
cantly greater number of dystrophin-positive myofibers
than the DEM-treated MDSCs (Figure 5, A–C). Furthermore,
there was no statistically significant difference between the
regeneration index of the DEM-treated MDSCs and myo-
blasts. Yet both of these groups had significantly less dys-
trophin-positive myofibers than untreated MDSCs (p 0.05;
Figure 5D). These results suggest that when the antioxidant
advantage of the MDSC is lost, the superior ability to regen-
erate dystrophin-positive myofibers is also lost.
Decreasing the GSH Levels of MDSCs Decreases the
Regeneration Capacity of MDSCs in Cardiac Muscle
We proceeded to determine whether decreased antioxidant
capacity would also decrease the regenerative capacity of
MDSCs in other tissues such as cardiac muscle. Induced
myocardial infarctions are a valuable injury model because
functional outcomes after cell transplantation can be mea-
sured using echocardiography. The goal of these experi-
ments was to measure the changes in MDSCs’ ability to
improve cardiac function after their antioxidant capacity
had been reduced.
Myocardial infarctions were induced in adult wild-type
C57 mice by ligating their left anterior descending artery
and which was followed by immediately injecting both cell
populations as previously reported (Oshima et al., 2005;
Payne et al., 2007). Functional analysis was performed using
echocardiography at 6 wk and histological analysis was
performed at 8 wk to measure the amount of fibrosis, the
degree of regeneration, and the capillary density at the
injection site.
Cross sections of hearts were stained with Mason
trichrome to measure the degree and area of fibrosis. On
microscopic observation, infarcted hearts injected with
DEM-treated MDSCs and PBS controls had comparable de-
grees of fibrosis, whereas both groups had more fibrosis
than untreated MDSCs (Figure 6A, 1–3). These results were
quantified by calculating the scar tissue ratio, defined as the
ratio of the area of fibrosis compared with the total cross-
sectional area of the heart. Infarcted hearts injected with
MDSCs treated with DEM and PBS displayed large and
comparable scar tissue ratios. In contrast, untreated MDSCs
had a significantly smaller scar tissue ratio than both of these
groups (p  0.05; Figure 6A, 4). These results suggest that
decreasing the antioxidant capacity of MDSCs also deterio-
Figure 4. Decreasing the levels of GSH in MDSCs, by treatment
with DEM, decreases the MDSCs’ resistance to stress. (A) Histogram
plots of GSH levels of MDSCs treated with increasing doses of DEM
(0, 5, 10, 50 M) compared with untreated myoblasts. (B) The
median fluorescence of the groups in A is shown for clarity. (C)
Rates of cell death for MDSCs treated with 50 M DEM, untreated
MDSCs, and untreated myoblasts after exposure to 100 M H2O2.
The area associated with each line represents the 95% CI of the
respective mean. Untreated MDSCs were included for reference; the
CI of this group is not included to increase visual clarity. (D)
Six-hour interval snapshots of C indicate that MDSCs treated with
DEM have rates of oxidative stress–induced cell death comparable
to that of myoblasts, and both groups have higher rates of cell death
compared with MDSCs. ANOVA; *p  0.05; mean values  CI are
shown, except in B where the median value  SEM is shown.
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rates the ability of MDSCs to improve cardiac wound heal-
ing and prevent adverse cardiac remodeling, such as scar
tissue.
Previously, we have shown that the vast majority of MD-
SCs and myoblasts injected into the heart differentiate into
skeletal myocytes expressing MHC (Oshima et al., 2005;
Payne et al., 2007). Interestingly, skeletal muscle engraftment
size in cardiac cell therapy does not correlate with functional
improvement after myocardial infarction. Instead, we have
shown that MDSC transplantation mitigates adverse remod-
eling of cardiac muscle after an infarction possibly by pro-
moting angiogenesis (Oshima et al., 2005; Payne et al., 2007).
As a result, we stained remodeling heart cross sections after
cell transplantation for CD31, an endothelial cell marker, to
measure possible differences in vascularity. On microscopic
observation, the vascularity of the infarction sites injected
with MDSCs treated with DEM and the PBS control were
comparable. Both of these groups appeared to have lower
numbers of CD31 cells than the infarction site of hearts
injected with MDSCs (Figure 6B, 1–3). The capillary density
was measured by counting the number of capillaries per
area of the infarcted myocardium in the image field. In-
farcted hearts injected with MDSCs treated with DEM and
PBS have statistically comparable capillary densities, and
both of these groups’ capillary densities are significantly
lower than hearts injected with MDSCs (p  0.05; Figure 6B,
4). These results suggest that decreasing the antioxidant
capacity of MDSCs impairs the cell population’s ability to
promote angiogenesis and mitigate adverse remodeling or
scar formation.
Echocardiography was performed to compare left ventri-
cle function 6 wk after infarction. Two-dimensional images
were obtained at diastole and systole to observe the contrac-
tion of the myocardium. M-mode tracings were used to
measure the EDD and ESD as previously described (Figure
7A; Oshima et al., 2005; Payne et al., 2007). No differences in
left ventricular cavity size as measured by the area of the
myocardium during diastole were observed among all three
groups as assessed by EDA (Figure 7B), a result commonly
observed in this type of experiments (Oshima et al., 2005;
Payne et al., 2005). As assessed by FS and FAC, infarcted
hearts injected with MDSCs had significantly better systolic
function relative to the infarcted hearts injected with both
MDSCs treated with DEM and PBS (p  0.05). Measuring
FS, infarcted hearts injected with MDSCs treated with DEM
had statistically increased systolic function compared with
hearts injected with PBS (p  0.05). Measuring FAC, in-
farcted hearts injected with MDSCs treated with DEM had
systolic function comparable to that of hearts injected with
PBS (Figure 7, C and D). Together, the functional experi-
ments suggest that when the antioxidant capacity of MDSCs
is decreased, MDSCs have a limited ability to repair cardiac
function.
DISCUSSION
Multiple cell populations have been investigated in clinical
and preclinical trials for dystrophic and cardiac muscle cell
therapies (Tremblay et al., 1993; Gussoni et al., 1997; Assmus
et al., 2006; Hagege et al., 2006; Lunde et al., 2006). However,
a mechanism that drives the variable regenerative capacities
between different cell populations in cell therapy has yet to
be fully elucidated. We investigated the possible role of
MDSCs’ antioxidant capacity in its superior regenerative ca-
pacity compared with myoblasts. Previous reports have shown
that MDSCs have an increased ability to regenerate dystro-
phin-positive myofibers in dystrophic skeletal muscle com-
pared with myoblasts (Qu-Petersen et al., 2002). Although
the increased regenerative capacity of MDSCs has often been
attributed to their long-term proliferation and multipotent
behavior, we demonstrate here that a resistance to stress
plays an important role in this process as well. MDSCs
display a high resistance to oxidative stress both in terms of
superior rates of differentiation and survival over that of
myoblasts. Furthermore the antioxidant capacity appears to
play a major role in the regenerative potential of MDSCs in
skeletal and cardiac muscles. Other groups have also dem-
onstrated that stem cell populations have increased resis-
tance to stress when compared with their more differenti-
ated counterparts (Dernbach et al., 2004; He et al., 2004).
Expanding on this work, we demonstrate that this increased
resistance to stress is a major determinant in the cell popu-
lation’s improved regenerative capacity in skeletal muscle
and in cardiac muscle at a functional level.
It was noted in this study that MDSCs were maintained at
a higher passage number than myoblasts. MDSCs can be
maintained in culture through 200 population doublings
with no evidence of neoplastic transformation, chromosome
Figure 5. Decreasing the antioxidant capac-
ity of MDSCs decreases the ability of MDSCs
to regenerate dystrophin-positive myofibers.
MDSCs treated and untreated with 50 M of
DEM and myoblasts were injected into the
skeletal muscle of Mdx mice that were sacri-
ficed at 2 wk, and the regeneration index (RI)
was measured. (A–C) Representative images
of the dystrophin-positive engraftments of
MDSCs, skeletal muscles treated with MDSCs,
and myoblasts, respectively, are shown. (B)
Bar, 50 m. (D) MDSCs treated with 50 M of
DEM had regeneration indices similar to that
of myoblasts and statistically significant lower
regeneration indices than untreated MDSCs.
ANOVA; *p  0.05; n 8 in each group; mean
values  SEM.
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abnormalities, or decrease in regenerative capacity (Deasy et
al., 2005). There is no evidence that MDSCs obtain increased
antioxidant capacity with increasing passage number; in-
deed, just the opposite has been reported in multiple groups
that have demonstrated that low passage cell populations
have an increased resistance to stress, antioxidant capacity,
and ability to withstand adverse environmental conditions
compared with higher passaged cell populations (Luce and
Cristofalo, 1992; Yuan et al., 1996; Kaneko et al., 2001; Gurjala
et al., 2005; Dowling et al., 2006).
Inflammation clearly is one of the most important hurdles
to overcome in order to increase the efficacy of cellular
therapies. A major source of the destructive power of in-
flammation is the direct and indirect generation of ROS and
free radicals after the inflammatory cytokine response
(Dhalla et al., 1999). In myogenic cell transplantation, a large
percentage of myoblasts die within 24–48 h after transplan-
tation into both skeletal and myocardial muscles, which
correlates with the time frame of an acute inflammatory
response that is observed at the site of injection (Beauchamp
et al., 1999; Gussoni et al., 1999; Oshima et al., 2005; Urish et
al., 2005). Furthermore and relevant to the cardiac studies
presented herein, the pathological hallmark after a myocar-
dial infarction is a rapid and strong inflammatory process
(Dhalla et al., 1999; Kaminski et al., 2002; Nian et al., 2004).
We postulated that one of the mechanisms behind the
MDSCs’ superior regenerative capacity may involve a resis-
tance to these stresses that occurs during cell transplanta-
tion. MDSCs consistently had lower rates of cell death and
increased rates of differentiation and fusion after exposure to
both H2O2 and TNF- when compared with myoblasts.
These results demonstrate that MDSCs possess different and
perhaps enhanced mechanisms of handling oxidative stress
and inflammation compared with myoblasts.
Different groups have reported that oxidative stress can
either induce a “differentiation checkpoint” (Puri et al., 2002)
or permanently force a cell into a state of senescence (Chen et
al., 2004). A differentiation checkpoint is similar to a cell cycle
check-point in that differentiation is arrested until the damage
has been repaired and the stress has dissipated. After exposure
to inflammatory cytokines such as TNF- or IL-1, myogenic
differentiation is inhibited through activation of the nuclear
Figure 6. Decreasing the antioxidant capacity of MDSCs decreases the ability of MDSCs to mitigate adverse remodeling after an induced
myocardial infarction. MDSCs, DEM-treated MDSCs, or PBS was injected into the infarction site. Animals were sacrificed at 8 wk for
histological analysis. (A) Mason trichrome staining was performed to measure fibrosis. Representative images of infarcted hearts injected
with MDSCs (A1), MDSCs treated with DEM (A2), and PBS (A3) are shown. Arrowheads indicate the main areas of infarcted myocardium.
Note the thin fibrotic walls in A2 and A3 compared with the small area of fibrosis in A1. Infarcted hearts injected with MDSCs had
significantly less fibrosis than hearts injected with MDSCs treated with DEM or PBS as measured by the scar tissue ratio (A4). (A2) Bar, 1000
m. (B) The vascularity of the infarcted area was measured by staining the sections for CD31, an endothelial cell marker. Representative
images of the capillary density of the infarcted area of hearts injected with MDSCs (B1), MDSCs treated with DEM (B2), and PBS (B3) are
shown. Arrowheads outline the myocardial wall. Note the reduced capillary density in the myocardium in B2 and B3 when compared with
B1. The capillary density was measured by counting the number of capillaries per pixel area. The infarcted area of hearts injected with MDSCs
had significantly higher capillary densities than hearts injected with MDSCs treated with DEM and PBS (B4). (B2) Bar, 50 m. (A4 and B4)
MDSCs  DEM, n  6; MDSCs, n  6; PBS control, n  5. ANOVA; *p  0.05; mean values  SEM.
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factor kappa B (NF-B) pathway (Guttridge et al., 1999; Langen
et al., 2004). Inhibiting the activation of NF-B in Mdx mice, a
mouse model of Duchenne muscular dystrophy, improves the
ability of muscle progenitor cells to proliferate, form myotubes,
and repair damaged muscle fibers (Kumar and Boriek, 2003;
Acharyya et al., 2007). Further, direct exposure to oxidative
stress inhibits myoblast differentiation through the same mech-
anism of NF-B activation (Catani et al., 2004).
Given that the NF-B pathways may be activated by both
oxidative and inflammatory stress, our results support these
observations. MDSCs demonstrated no change in their abil-
ity to fuse and form myotubes after in vitro exposure to
oxidative stress in the form of H2O2 and TNF-. Myoblasts
exposed to increased levels of oxidative stress and an in-
flammatory cytokine had a temporary decrease in the ability
to differentiate, and when this stress was removed, myo-
blasts resumed differentiation. If myogenic differentiation is
inhibited via the NF-B pathway, this implies that MDSCs may
maintain their rate of differentiation after they are exposed to
inflammatory and oxidative stresses by mitigating NF-B acti-
vation.
The phenotypic differences in survival and differentiation
between MDSCs and myoblasts could be explained by the
antioxidant capacity of each population. When the GSH
level of MDSCs was reduced to levels similar to myoblasts to
decrease antioxidant capacity, MDSCs’ capacity to regener-
ate both skeletal and cardiac muscles was decreased to that
of myoblasts. We also showed that these differences were
manifested at a functional level in the myocardial infarction
animal model. The suggestion that stem cells have an in-
creased resistance to oxidative stress compared with their
more differentiated progeny has been described previously
(Dernbach et al., 2004; He et al., 2004). Other studies focused
on the importance of stress in the transplantation process by
genetically engineering the transplanted cell population to
resist the effects of inflammation and stress, most notably
Figure 7. Decreasing the antioxidant capacity of MDSCs decreases the abil-
ity of MDSCs to improve cardiac function after an induced myocardial
infarction. After myocardial infarctions were induced, functional analysis was
performed at 6 wk using echocardiography. (A) Representative echocardio-
graph images of one of the MDSC groups are shown to demonstrate func-
tional measurements. Two-dimensional echocardiograph images of the left
ventricle at diastole and systole used to calculate FAC are shown. The
myocardium is outlined to demonstrate the change in area during contraction
between diastole and systole. The widest diameter of the ventricle during
diastole in the two-dimensional echocardiograph image, as indicated by the
dashed line, was followed for a period of time over consecutive heartbeats as
shown in the M-mode tracing. EDD and ESD were measured to calculate FS.
(B) Infarcted hearts injected with MDSCs, MDSCs treated with DEM, and PBS
all have similar values of EDA indicating these groups have comparable left
ventricular cavity size after infarction. (C) Hearts injected with MDSCs have
a significantly increased FS compared with MDSCs treated with DEM and the
PBS control, indicating improved cardiac function. Infarcted hearts injected
with MDSCs treated with DEM and PBS have comparable FS, indicating similar cardiac function after infarction. (D) Hearts injected with
MDSCs have a significantly increased FAC compared with MDSCs treated with DEM and the PBS control indicating improved contractile
function. Both groups of MDSCs have an increased FAC over the PBS control. (B–D) MDSCsDEM, n  8; MDSCs, n  7; PBS control, n  8.
ANOVA; *p  0.05; mean values  SEM.
K. L. Urish et al.
Molecular Biology of the Cell518
with heat-shock proteins (Suzuki et al., 2000; Zhang et al.,
2001). In this study we extend these findings by showing
that the MDSCs’ superior antioxidant capacity not only im-
proves its regenerative capacity in skeletal and cardiac mus-
cle but enhances the host tissue’s ability to mitigate adverse
remodeling in the case of infracted myocardium.
The term “stemness” has been used to describe the prop-
erties that define a stem cell and its molecular signature
(Ivanova et al., 2002; Ramalho-Santos et al., 2002; Dernbach et
al., 2004). These include the upregulation of genes responsi-
ble for self-renewal, long-term proliferation, and multipo-
tent differentiation. An emerging stem cell property is its
antioxidant capacity and corresponding response to oxida-
tive and inflammatory stresses. After an injury, a toxic en-
vironment can be created from inflammation, ischemia,
reperfusion, and the ensuing inflammatory cytokine storm.
A stem cell’s ability to function as a regenerative building
block depends on its capacity to withstand and perhaps
respond to this noxious environment.
In this study we have observed an increased antioxidant
capacity in MDSCs that we believe is a critical if not neces-
sary feature of their superior regeneration capacity in skel-
etal and cardiac muscles. This feature not only suggests that
the MDSCs may have a higher stress capacity than myoblasts,
but it also lends credence to our emerging understanding of
how an enhanced resistance to oxidative and inflammatory
stress pertains to the concept of cellular “stemness.”
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